Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats.
Second-by-second analysis of alpha 7 nicotine receptor regulation of glutamate release in the prefrontal cortex of awake rats.
复制标题
DOI:
10.1002/syn.20693
复制
发表时间:
2009-12
期刊:
影响因子:
2.3
通讯作者:
Bruno, John P.
中科院分区:
文献类型:
--
作者:
Konradsson-Geuken, Asa;Gash, Clelland R.;Alexander, Kathleen;Pomerleau, Francois;Huettl, Peter;Gerhardt, Greg A.;Bruno, John P.
These experiments utilized an enzyme-based microelectrode selective for the second-by-second detection of extracellular glutamate to reveal the α7-based nicotinic modulation of glutamate release in the prefrontal cortex (PFC) of freely moving rats. Rats received intra-cortical infusions of the non-selective nicotinic agonist nicotine (1.0 μg/0.4 μL) or the selective α7 agonist choline (2.0 mM/0.4 μL). The selectivity of drug-induced glutamate release was assessed in subgroups of animals pre-treated with the α7 antagonist, α-bungarotoxin (α-BGT, 10 μM) or kynurenine (10 μM) the precursor of the astrocyte-derived, negative allosteric α7 modulator kynurenic acid. Local administration of nicotine increased glutamate signals (maximum amplitude = 4.3 ± 0.6 μM) that were cleared to baseline levels in 493 ± 80 sec. Pre-treatment with α-BGT or kynurenine attenuated nicotine-induced glutamate by 61% and 60%, respectively. Local administration of choline also increased glutamate signals (maximum amplitude = 6.3 ± 0.9 μM). In contrast to nicotine-evoked glutamate release, choline-evoked signals were cleared more quickly (28 ± 6 sec) and pre-treatment with α-BGT or kynurenine completely blocked the stimulated glutamate release. Using a method that reveals the temporal dynamics of in vivo glutamate release and clearance, these data indicate a nicotinic modulation of cortical glutamate release that is both α7 – and non-α7-mediated. Furthermore, these data may also provide a mechanism underlying the recent focus on α7 full and partial agonists as therapeutic agents in the treatment of cortically-mediated cognitive deficits in schizophrenia.
登录
查看更多内容
影响因子:
5.3
作者:
Bitner, Robert S.;Bunnelle, William H.;Gopalakrishnan, Murali
通讯作者:
Gopalakrishnan, Murali
影响因子:
3.4
作者:
Foulds, J;Stapleton, J;Russell, MAH
通讯作者:
Russell, MAH
影响因子:
2.9
作者:
Chiba, T
通讯作者:
Chiba, T
影响因子:
7.4
作者:
Kulagina, NV;Shankar, L;Michael, AC
通讯作者:
Michael, AC
影响因子:
64.8
作者:
Gray, R;Rajan, AS;Dani, JA
通讯作者:
Dani, JA